HTA Database - Search Results

Sort by Relevance

Search Results [1476 Hits] Selected Records [0 Hits] [Clear]

Year	Source	Title
2023	Ontario Health	Supplemental Screening as an Adjunct to Mammography for Breast Cancer Screening in People With Dense Breasts
2023	Health Information and Quality Authority (HIQA)	Health technology assessment of the addition of severe combined immunodeficiency (SCID) to the National Newborn Bloodspot Screening Programme
2023	Health Information and Quality Authority (HIQA)	A rapid health technology assessment of gene expression profiling tests for guiding the use of adjuvant chemotherapy in early-stage invasive breast cancer
2023	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: characteristics and needs of targeted rehabilitation clienteles for young people with adjustment problems aged 10 or older]
2023	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Evaluation of the lung cancer screening program]
2023	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Ovarian tissue cryopreservation and transplantation in patients with cancer or benign diseases to fertility preservation]
2023	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Early detection tools for emotional distress in adult people with cancer]
2023	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: assessment of the relevance of tandem mass spectrometry-based newborn blood spot screening for glutaric acidemia type 1 (GA1)]
2023	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: assessment of the relevance of tandem mass spectrometry-based newborn blood spot screening for for long-chain acyl-CoA dehydrogenase deficiency (LCHADD) and mitochondrial trifunctional protein deficiency (TFPD)]
2023	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: assessment of the relevance of tandem mass spectrometry-based newborn blood spot screening for very long-chain acyl-CoA dehydrogenase deficiency (VLCADD)]
2023	NIHR Health Technology Assessment programme	Motivational support intervention to reduce smoking and increase physical activity in smokers not ready to quit: the TARS RCT
2023	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guides and standards: Syphilis - detection, diagnosis, optimal antibiotic use, and follow-up]
2023	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: NK cell degranulation (natural killer)]
2023	NIHR Health and Social Care Delivery Program	Mental health crisis care for children and young people aged 5 to 25 years: the CAMH-Crisis evidence synthesis
2023	NIHR Health Technology Assessment programme	Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial
2023	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: relevance of adding the HbS/E, HbE/E and HbE/β-thal variants to the primary targets of the neonatal screening test for hemoglobinopathies]
2023	Austrian Institute for Health Technology Assessment (AIHTA)	Perinatal and infant mental health care in Austria. A mapping of existing prevention, screening and care structures, with a specific focus on Tyrol
2023	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: principles and criteria for gene selection for the molecular diagnosis of constitutional genetic diseases by next-generation sequencing - Report in support of the deployment of the sequencing service]
2023	Penn Medicine Center for Evidence-based Practice (CEP)	Urine pregnancy screening for patients with and without the capacity for pregnancy
2023	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guides and standards: measurement and monitoring of total serum bilirubin in a newborn with signs suggestive of neonatal jaundice]
2023	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: optical genome mapping - diagnosis and prognostic stratification of hematological malignancies]
2023	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: virtual care in hematology/oncology]
2023	Institut national d'excellence en sante et en services sociaux (INESSS)	[Rapid response: Cervical cancer: transition from from Pap test screening to HPV testing]
2023	NIHR Health Services and Delivery Research programme	What happens after an NHS Health Check? A survey and realist review
2023	NIHR Health Services and Delivery Research programme	Identifying models of care to improve outcomes for older people with urgent care needs: a mixed methods approach to develop a system dynamics model
2023	NIHR Health Services and Delivery Research programme	Integration, effectiveness and costs of different models of primary health care provision for people who are homeless: an evaluation study
2023	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Evaluation of invitation letters and information for insured persons on colorectal cancer screening]
2023	NIHR Health Services and Delivery Research programme	Reducing unplanned hospital admissions from care homes: a systematic review
2023	NIHR Health Technology Assessment programme	Online remote behavioural intervention for tics in 9- to 17-year-olds: the ORBIT RCT with embedded process and economic evaluation
2023	NIHR Health Technology Assessment programme	Posterior cervical foraminotomy versus anterior cervical discectomy for cervical brachialgia: the FORVAD RCT
2023	NIHR Health Technology Assessment programme	Exercise therapy for tendinopathy: a mixed-methods evidence synthesis exploring feasibility, acceptability and effectiveness
2023	NIHR Health Services and Delivery Research programme	The effectiveness of sexual assault referral centres with regard to mental health and substance use: a national mixed-methods study – the MiMoS Study
2023	Canary Health Service	[Evaluation of the lung cancer screening program]
2023	Institut national d'excellence en sante et en services sociaux (INESSS)	[At a glance: screening and management algorithm management of precancerous lesions - cervical cancer and population-based screening]
2023	NIHR Health Services and Delivery Research programme	Remote monitoring for long-term physical health conditions: an evidence and gap map
2023	Canary Health Service	[Cost-effectiveness of newborn screening for tyrosinemia type I (update)]
2023	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Cost-utility analysis of universal neonatal screening for critical congenital heart disease based on pulsioximetry in Spain]
2023	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guides and standards: urinary tract infection in people aged 14 and over - diagnostic guidelines, optimal use of 1st- and 2nd-line treatments and follow-up ]
2023	Health Information and Quality Authority (HIQA)	Health technology assessment of the addition of spinal muscular atrophy (SMA) to the National Newborn Bloodspot Screening Programme
2023	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: assessment of Intercept and Mirasol - pathogen reduction technologies for the treatment of labile blood products in Quebec]
2023	Austrian Institute for Health Technology Assessment (AIHTA)	SMA therapies: mid- to long-term follow-up of spinal muscular atrophy (SMA) patients treated for ≥24 months with nusinersen or onasemnogene abeparvovec and ≥12 months for patients treated with risdiplam or combination therapies
2023	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Safety, efficacy, and economic evaluation of the implementation of an abdominal aortic aneurysm screening program]
2023	Ontario Health	Carrier screening programs for cystic fibrosis, fragile X syndrome, hemoglobinopathies and thalassemia, and spinal muscular atrophy
2023	Andalusian Health Technology Assessment Area (AETSA)	[Clinical effectiveness and safety of newborn screening for spinal muscular atrophy. Systematic review]
2023	Canary Health Service	[Clinical effectiveness and cost-effectiveness of the extension of colorectal cancer screening up to 74 years of age in general population]
2022	Swiss Federal Office of Public Health (FOPH)	Thyroid function tests for the diagnosis of suspected primary or secondary thyroid dysfunction
2022	Basque Office for Health Technology Assessment (OSTEBA)	[Autism spectrum disorder: scientific evidence on its detection, diagnosis and treatment]
2022	Basque Office for Health Technology Assessment (OSTEBA)	[Temporary percutaneous circulatory support devices for the treatment and prevention of cardiogenic shock: analysis of efficacy, effectiveness and safety]
2022	NIHR Health Technology Assessment programme	Dynamic contrast-enhanced CT compared with positron emission tomography CT to characterise solitary pulmonary nodules: the SPUtNIk diagnostic accuracy study and economic modelling
2022	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: practices for screening or reducing psychological symptoms in individuals with a post-COVID-19 condition]
2022	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: cervical cancer screening in Québec - recommendations for implementing the human papillomavirus detection test (HPV test) as the primary screening test]
2022	Penn Medicine Center for Evidence-based Practice (CEP)	Breast cancer risk assessment tools
2022	Penn Medicine Center for Evidence-based Practice (CEP)	Structured screening questionnaires for alcohol misuse/alcohol use disorders
2022	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: evaluation of the relevance of newborn screening for severe combined immunodeficiency SCID]
2022	Austrian Institute for Health Technology Assessment (AIHTA)	Regulation and financing of prenatal screening and diagnostic examinations for fetal anomalies in selected European countries
2022	NIHR Health Services and Delivery Research programme	Components of interventions to reduce restrictive practices with children and young people in institutional settings: the Contrast systematic mapping review
2022	Ontario Health	First-trimester screening program for the risk of pre-eclampsia using a multiple-marker algorithm: a health technology assessment
2022	NIHR Health Technology Assessment programme	Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis
2022	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: Hereditary Cardiovascular diseases NGS Panel - Evaluation report on the repatriation of an analysis carried out outside of the province of Québec]
2022	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guides and standards: update of the optimal usage guide on sexually transmitted and blood borne infections – confirmed Mycoplasma genitalium infection]
2022	Austrian Institute for Health Technology Assessment (AIHTA)	[Risk-based breast cancer screening in Austria: a systematic analysis of predictive models to assess individual breast cancer risk, their utility and applicability in a breast cancer screening programme]
2022	Norwegian Institute of Public Health (NIPH)	First trimester-screening for the development of preeclampsia with the use of an algorithm: a health technology assessment
2022	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Search for guidelines on population-based colorectal cancer screening]
2022	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Review of age limits in the mammography screening programme]
2022	Andalusian Health Technology Assessment Area (AETSA)	[Clinical effectiveness, safety, and economic assessment of mass screening for hepatitis C. Systematic review]
2022	NIHR Health Technology Assessment programme	Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling
2022	NIHR Health Technology Assessment programme	EarlyCDT Lung blood test for risk classification of solid pulmonary nodules: systematic review and economic evaluation
2022	Austrian Institute for Health Technology Assessment (AIHTA)	Perinatal and infant mental health care models and pathways
2022	Malaysian Health Technology Assessment (MaHTAS)	Early cancer detection test for lung (EarlyCDT-Lung)
2022	Institute for Clinical Effectiveness and Health Policy (IECS)	[Adjunctive colposcopy technologies (videocolposcopy) for cervical conditions]
2022	Institute for Clinical Effectiveness and Health Policy (IECS)	[Prenatal cell-free DNA in maternal blood screening to assess chromosomal disorders in single pregnancy]
2022	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: assessment of the relevance of tandem mass spectrometry-based newborn blood spot screening for argininosuccinic aciduria (ASA)]
2022	Scottish Health Technologies Group (SHTG)	The Psychology Adding Value – Epilepsy Screening (PAVES) and early intervention for children and young people with epilepsy at risk of mental health problems
2022	Health Sciences Institute in Aragon (IACS)	[Digital dermatoscopy]
2022	Institute for Clinical Effectiveness and Health Policy (IECS)	[Digital breast tomosynthesis]
2022	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Screening tools for frailty in users undergoing cardiac surgery requiring a sternotomy]
2022	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Systematic review on diagnosis and care of reactive attachment disorder]
2022	Ontario Health	Genetic testing for familial hypercholesterolemia
2022	The Regional Health Technology Assessment Centre (HTA-centrum)	Progesterone, cerclage, pessary, or acetylsalicylic acid for prevention of preterm birth in singleton and multifetal pregnancies
2022	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Blood values: do older people benefit from regular determination of vitamin B12 and vitamin D levels in the blood?]
2022	Norwegian Institute of Public Health (NIPH)	Zephyr® valves system in the treatment of emphysema: a single technology assessment
2021	NIHR Health Technology Assessment programme	The cystic fibrosis (CF) anti-staphylococcal antibiotic prophylaxis trial (CF START); a randomised registry trial to assess the safety and efficacy of flucloxacillin as a longterm prophylaxis agent for infants with CF
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: noninvasive fetal RhD genotyping using maternal plasma]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: artificial intelligence-assisted diabetic retinopathy tele-screening]
2021	NIHR Health Technology Assessment programme	Universal late pregnancy ultrasound screening to predict adverse outcomes in nulliparous women: a systematic review and cost-effectiveness analysis
2021	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Newborn screening for classic congenital adrenal hyperplasia. Update and assessment of regional programs]
2021	Austrian Institute for Health Technology Assessment (AIHTA)	[Parent-Child-Pass Update 2020/21 – Screenings for mental health, nutrition and social competence]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: initiating blood work for the purpose of evaluating diagnosed or suspected alcohol use disorder]
2021	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Screening for common mental disorders during pregnancy and for traumatic experiences after delivery]
2021	NIHR Health Technology Assessment programme	Modelling tool to support decision-making in the NHS Health Check programme: workshops, systematic review and co-production with users
2021	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Recommendations for the appropriate use of vitamin D tests and supplements in the general population]
2021	Penn Medicine Center for Evidence-based Practice (CEP)	Palliative care screening tools
2021	Institute for Clinical Effectiveness and Health Policy (IECS)	[Genetic testing for lynch syndrome in colorectal cancer and family members]
2021	NIHR Public Health Research (PHR) programme	School-based interventions to prevent anxiety, depression and conduct disorder in children and young people: a systematic review and network meta-analysis
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: relevance of using mpMRI for the diagnostic investigation of prostate cancer - mpMRI and prostate cancer diagnosis]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: relevance of neonatal pulse oximetry screening for critical congenital heart disease]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: mammographic density and breast cancer screening]
2021	Health Information and Quality Authority (HIQA)	Extended interval screening by the Diabetic RetinaScreen Programme in Ireland
2021	Health Information and Quality Authority (HIQA)	Potential impact of different serial testing scenarios using rapid antigen detection tests (RADTs) to detect SARS-CoV-2 in meat processing plant workers
2021	Health Information and Quality Authority (HIQA)	Review of processes in use to inform the expansion of newborn bloodspot screening programmes